Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial
מצבים רפואיים
Advanced Alveolar Soft Part Sarcoma · Advanced Soft Tissue Sarcoma · Metastatic Alveolar Soft Part Sarcoma · Refractory Alveolar Soft Part Sarcoma · Unresectable Alveolar Soft Part Sarcoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Keck Medicine of USC Koreatown, Los Angeles, California, United States
Contact: Principal Investigator (Mark Agulnik)Los Angeles General Medical Center, Los Angeles, California, United States
Contact: Principal Investigator (Mark Agulnik)USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
Contact: Principal Investigator (Mark Agulnik)Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States
Contact: Principal Investigator (Philippos Apolinario Costa)Yale University, New Haven, Connecticut, United States
Contact: Principal Investigator (Philippos Apolinario Costa)Smilow Cancer Hospital Care Center-Trumbull, Trumbull, Connecticut, United States
Contact: Principal Investigator (Philippos Apolinario Costa)MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States
National Cancer Institute Developmental Therapeutics Clinic, Bethesda, Maryland, United States
Contact: Principal Investigator (A P. Chen)National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Contact: Principal Investigator (David A. Liebner)University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Contact: Principal Investigator (Minh Phan)University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Melissa A. Burgess)UT MD Anderson Cancer Center, Houston, Texas, United States
מובילי המחקר
A P Chen
Principal Investigator
National Cancer Institute LAO